About this study

We’re currently investigating the effects of a DHA-rich omega-3 powder on cognition, mood and cardiovascular health. 

This study involves three visits to the Centre for Human Psychopharmacology over a 1-month period.

You may be eligible for this study if you:

  • are male, aged between 40–60 years
  • are in good general health
  • are a non-smoker
  • have no history of other significant medical conditions such as heart disease, diabetes, psychiatric disorders, neurological conditions
  • have no fish or milk allergies.

Note: Additional eligibility criteria may apply to participate in this study.

Testing sessions involve computerised cognitive testing and mood questionnaires. Participants will be compensated with $150 for their time.

Study progress

This trial has finished recruitment and study findings will be available soon.

For further enquiries

Jeff Reddan

+61 3 9214 8259


Our research ethics and integrity

Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.

Contact the Centre for Human Psychopharmacology

There are many ways to engage with us. If your organisation is dealing with a complex problem, get in touch to discuss how we can work together to provide solutions. Call us on +61 3 9214 4444 or email chp@swinburne.edu.au

Contact us